Hilary Brooks
VP and Modality lead for Oligonucleotide Therapeutics at Evotec
False
Advertisement
How Oligonucleotides Work Their Magic
August 20, 2025
Pharma is investing big in oligonucleotides, but what is it that makes this class of drugs so special? We find out.
10 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
